Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Onconova Therapeutic (ONTX)

Onconova Therapeutic (ONTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Onconova Therapeutic 12 PENNS TRAIL NEWTOWN PA 18940 USA

www.onconova.com P: 267-759-3680

Description:

Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecule drug candidates to treat cancer. The Company's products under different phases of development include Rigosertib intravenous (IV), Rigosertib Oral, Rigosertib IV, ON 013105 and Recilisib. Onconova Therapeutics, Inc. is headquartered in Newtown, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 20,904
Enterprise Value, $K -17,856
Shares Outstanding, K 21,003
Annual Sales, $ 230 K
Annual Net Income, $ -18,960 K
Last Quarter Sales, $ 60 K
Last Quarter Net Income, $ -4,740 K
EBIT, $ -21,570 K
EBITDA, $ -21,560 K
60-Month Beta 1.38
% of Insider Shareholders 3.30%
% of Institutional Shareholders 7.95%
Float, K 20,310
% Float 96.70%
Short Volume Ratio 0.18

Growth:

1-Year Return 36.21%
3-Year Return -91.92%
5-Year Return -98.23%
5-Year Revenue Growth -70.89%
5-Year Earnings Growth 99.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 11/14/23
Next Earnings Date 05/20/24
Earnings Per Share ttm -0.97
EPS Growth vs. Prev Qtr 13.04%
EPS Growth vs. Prev Year 23.08%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 05/21/21

ONTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -8,243.48%
Debt/Equity 0.00
Price/Sales 91.38
Price/Cash Flow N/A
Price/Book 1.96
Book Value/Share 0.69
Interest Coverage -1.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar